Global opioid use disorder market to See Huge Growth by 2026 | Indivior PLC; Teva Pharmaceutical Industries Ltd.; Omeros Corporation; Camurus

Global opioid use disorder market is expected to rise to an estimated value of USD 4.22 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the various initiatives undertaken by authorities of different regions to combat the opioid abuse prevalent in the global population.

Global Opioid Use Disorder Market By Drug (Buprenorphine, Methadone, Naltrexone), Application (Moderate Pain Treatment, Severe Pain Treatment), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2026

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-opioid-use-disorder-market&Captain

Key Market Competitors:

Few of the major competitors currently working in the global opioid use disorder market are Indivior PLC; Teva Pharmaceutical Industries Ltd.; Omeros Corporation; Camurus; Hikma Pharmaceuticals PLC; Titan Pharmaceuticals, Inc.; BioDelivery Sciences International, Inc.; Alkermes; Novartis AG; Pear Therapeutics, Inc.; Amygdala Neurosciences, Inc.; Orexo AB (publ.); Braeburn Inc.; iX Biopharma Ltd.; Relmada Therapeutics, Inc. and Mundipharma International among others.

Competitive Analysis:

Global opioid use disorder market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of opioid use disorder market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Definition:�Global Opioid Use Disorder Market

Opioid use disorder is a condition in which patients are addicted/dependent on consumption of opioids. This disorder is generally segregated into two categories: patients reliant on medicinal opioid drugs and opioid available as non-medicinal. This disorder is generally associated with a number of factors that are environmental and genetic resulting in it arising in patients.

Market Drivers

Increasing intensity of opioid epidemic in the North America region is expected to fuel the growth of the market
Strong pipeline of pharmaceuticals and expected commercialization of these products is expected to boost the growth of the market

Market Restraint

Complications associated with the reimbursement scenarios for addiction therapies; this factor is expected to restrict the growth of the market

Grab Your Report at an Impressive 30% Discount! Please click here@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-opioid-use-disorder-market�

Segmentation: Global Opioid Use Disorder Market

By Drug

Buprenorphine
Bunavail
Sublocade
Suboxone
Zubsolv
Others
Methadone
Naltrexone

By Application

Moderate Pain Treatment
Severe Pain Treatment

By�Geography

North America
Europe
Asia-Pacific
South America
Middle East and Africa

Key Developments in the Market:

In February 2019, Titan Pharmaceuticals, Inc. announced that they had entered into an agreement with AllianceRx Walgreens Prime for the expansion of accessibility of patients for Titan's opioid use disorder implant branded as "Probuphine implant". This agreement comes after the company identified the areas through which the majority of sales for these products are set to be generated, i.e. pharmacy distribution. This will enhance the ability of patients to avail highly effective treatment solutions for opioid use disorder
In January 2019, Novartis AG's business division Sandoz Inc. along with Pear Therapeutics, Inc. announced that they had launched "reSET-O" commercially for patients suffering from opioid use. The product is available immediately after the company had received clearance from the US FDA in December. "reSET-O" is digital prescription based 12-week behavioral therapeutic system for outpatient treatment. This availability will help in serving the wide-spread unmet need of effective opioid use disorder treatment systems

Reasons to Purchase this Report

Current and future of global opioid use disorder market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.